camptothecin has been researched along with tafluposide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barret, JM; Etiévant, C; Hill, BT; Imbert, T; Kruczynski, A; Perrin, D; van Hille, B | 1 |
| Barret, JM; Hill, BT; Olive, PL | 1 |
2 other study(ies) available for camptothecin and tafluposide
| Article | Year |
|---|---|
F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Catalysis; Cattle; Cell Nucleus; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Enzyme Stability; Etoposide; Evaluation Studies as Topic; Humans; Naphthalenes; Pyrans; Saccharomyces cerevisiae; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2000 |
Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases.
Topics: Animals; Camptothecin; Cell Line; Comet Assay; DNA; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Etoposide; Naphthalenes; Pyrans; Spheroids, Cellular; Time Factors; Topoisomerase I Inhibitors | 2000 |